Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial

Publisher： Karger

E-ISSN： 1423-0232|89|1|23-30

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.1, 2015-01, pp. : 23-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 5, 2015-05 ,pp. : 514-522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma

By  

Oncology, Vol. 76, Iss. 1, 2008-11 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Phase II Study of Single-Agent Pegylated Liposomal Doxorubicin HCl (PLD) in Metastatic Breast Cancer After First-Line Treatment Failure

By  

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 441-446

Karger

Access to resources Recommend Favorite

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 4, 2015-04 ,pp. : 404-409

John Wiley & Sons Inc

Access to resources Recommend Favorite